Hathaway JT, et al
Sci Rep (2015) 5:16831.10.1038/srep16831 Summary Keywords incretins, ER stress, diabetes mellitus, microbiota, inflammation, enteroendocrine cells, glucagon-like peptide 1, inflammatory bowel disease Citation Zietek T and Rath E (2016) Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
Utilization management tools are intended to balance cost control and access but may still pose barriers for people with a medical necessity to take these drugs
As men lose weight through GLP-1 weight loss for men , many experience improvements in metabolic health, which can positively influence hormone balance
We outline new mechanistic concepts, future therapeutic opportunities, potential for differentiation from currently available medicines and areas of uncertainty requiring additional investigation
Conclusion: Saroglitazar is safe and more effective than simvastatin in reducing steatosis in patients with Met-ALD